In CRC tissue, miR-17 downregulates RBL2, leading to carcinogenic Wnt/ß-catenin induction [147], but has also shown the potential inhibition of colorectal cancer invasiveness when used in isolation [148]. This evidence concerns the gene RBL2 and colorectal carcinoma.